Orthofix Medical Inc. revised earnings guidance for the year 2024. For the year, the company expects net sales to range between $790 million to $795 million, representing implied growth of 6% to 7% year-over-year on a constant currency basis; narrowed from previous guidance of $785 million to $795 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.73 USD | -3.45% | -7.67% | +1.85% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.85% | 534M | |
-7.16% | 177B | |
-4.86% | 65.54B | |
-4.28% | 47.09B | |
+10.32% | 43.43B | |
+8.14% | 41.77B | |
+15.76% | 29.55B | |
+15.53% | 24.83B | |
-5.88% | 23.97B | |
-5.38% | 23.54B |
- Stock Market
- Equities
- OFIX Stock
- News Orthofix Medical Inc.
- Orthofix Medical Inc. Revises Earnings Guidance for the Year 2024